{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:56:26Z","timestamp":1791899786044,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35NS111583"],"award-info":[{"award-number":["R35NS111583"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000952","name":"Paul G Allen Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003187","name":"NSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019319","name":"Ressler Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.celrep.2022.111953","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T23:48:42Z","timestamp":1673048922000},"page":"111953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neuronal and astrocytic contributions to Huntington\u2019s disease dissected with zinc finger protein transcriptional repressors"],"prefix":"10.1016","volume":"42","author":[{"given":"Mohitkumar R.","family":"Gangwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joselyn S.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Jami-Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srushti","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riki","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Wohlschlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0939-1218","authenticated-orcid":false,"given":"Baljit S.","family":"Khakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.111953_bib1","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.celrep.2022.111953_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111953_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI45364","article-title":"The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease","volume":"121","author":"Munoz-Sanjuan","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2022.111953_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2022.111953_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410370213","article-title":"Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals","volume":"37","author":"Landwehrmeyer","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2022.111953_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","article-title":"Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation","volume":"107","author":"Lee","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111953_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2022.111953_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/glia.23050","article-title":"Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific","volume":"65","author":"Jansen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.celrep.2022.111953_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.celrep.2022.111953_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2022.111953_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in huntington's disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.celrep.2022.111953_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.celrep.2022.111953_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington's disease","volume":"33","author":"Plotkin","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.celrep.2022.111953_bib14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41591-019-0478-3","article-title":"Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease","volume":"25","author":"Zeitler","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2022.111953_bib15","doi-asserted-by":"crossref","first-page":"eaaw8546","DOI":"10.1126\/scitranslmed.aaw8546","article-title":"Astrocyte molecular signatures in Huntington\u2019s disease","volume":"11","author":"Diaz-Castro","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111953_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2022.111953_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.12703\/r\/10-77","article-title":"Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion","volume":"10","author":"Kaye","year":"2021","journal-title":"Fac. Rev."},{"key":"10.1016\/j.celrep.2022.111953_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JHD-190389","article-title":"Transcriptional assessment of striatal mRNAs as valid biomarkers of disease progression in three mouse models of huntington's disease","volume":"9","author":"Ghavami","year":"2020","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.celrep.2022.111953_bib19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.2967\/jnumed.121.262709","article-title":"Synaptic vesicle glycoprotein 2A is affected in the central nervous system of mice with huntington disease and in the brain of a human with huntington disease postmortem","volume":"63","author":"Bertoglio","year":"2022","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.celrep.2022.111953_bib20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in huntington's disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111953_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1212\/WNL.0000000000002391","article-title":"Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging","volume":"86","author":"Russell","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2022.111953_bib22","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1038\/s41467-020-18255-5","article-title":"DNA methylation study of Huntington's disease and motor progression in patients and in animal models","volume":"11","author":"Lu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111953_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2016.11.013","article-title":"Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: a cross-validation study in Q175 knock-in mice","volume":"98","author":"Shankaran","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2022.111953_bib24","doi-asserted-by":"crossref","first-page":"e0243052","DOI":"10.1371\/journal.pone.0243052","article-title":"Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease","volume":"15","author":"Heikkinen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111953_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jneumeth.2017.04.020","article-title":"Characterisation of progressive motor deficits in whisker movements in R6\/2, Q175 and Hdh knock-in mouse models of Huntington's disease","volume":"300","author":"Garland","year":"2018","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.celrep.2022.111953_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nbt.3587","article-title":"Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice","volume":"34","author":"Alexandrov","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2022.111953_bib27","doi-asserted-by":"crossref","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111953_bib28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.neuron.2018.08.015","article-title":"Reducing astrocyte calcium signaling in\u00a0vivo alters striatal microcircuits and causes repetitive behavior","volume":"99","author":"Yu","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111953_bib29","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.neuron.2020.09.021","article-title":"Context-specific striatal astrocyte molecular responses are phenotypically exploitable","volume":"108","author":"Yu","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111953_bib30","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.celrep.2022.111953_bib31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2022.111953_bib32","doi-asserted-by":"crossref","first-page":"797220","DOI":"10.3389\/fnagi.2022.797220","article-title":"Altered cholesterol homeostasis in huntington's disease","volume":"14","author":"Kacher","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.celrep.2022.111953_bib33","doi-asserted-by":"crossref","first-page":"109308","DOI":"10.1016\/j.celrep.2021.109308","article-title":"Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease","volume":"36","author":"Benraiss","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2022.111953_bib34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2022.111953_bib35","doi-asserted-by":"crossref","first-page":"fcab105","DOI":"10.1093\/braincomms\/fcab105","article-title":"Use of high-content imaging to quantify transduction of AAV-PHP viruses in the brain following systemic delivery","volume":"3","author":"Smith","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.celrep.2022.111953_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.celrep.2022.111953_bib37","article-title":"Expression analysis of Huntington disease mouse models reveals robust striatum disease signatures","author":"Obenauer","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2022.111953_bib38","doi-asserted-by":"crossref","first-page":"e60012","DOI":"10.1371\/journal.pone.0060012","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/2 mouse model of HD","volume":"8","author":"Rattray","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.111953_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2005.03348.x","article-title":"Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers","volume":"95","author":"Hoffner","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2022.111953_bib40","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2022.111953_bib41","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/s41467-018-06281-3","article-title":"Regulatory mechanisms of incomplete huntingtin mRNA splicing","volume":"9","author":"Neueder","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111953_bib42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41598-017-01510-z","article-title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients","volume":"7","author":"Neueder","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.111953_bib43","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/jnr.24493","article-title":"Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene","volume":"97","author":"Franich","year":"2019","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.celrep.2022.111953_bib44","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1038\/s41598-019-52411-2","article-title":"Extensive expression analysis of Htt transcripts in brain regions from the zQ175 HD mouse model using a QuantiGene multiplex assay","volume":"9","author":"Papadopoulou","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.111953_bib45","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.celrep.2022.111953_bib46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","article-title":"Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological and functional evidence","volume":"95","author":"Chai","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111953_bib47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuron.2016.11.030","article-title":"New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes in\u00a0situ and in\u00a0vivo","volume":"92","author":"Srinivasan","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2022.111953_bib48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","article-title":"Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease","volume":"330","author":"Birolini","year":"2021","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.celrep.2022.111953_bib49","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awab186","article-title":"SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes","volume":"144","author":"Birolini","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2022.111953_bib50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neulet.2011.03.025","article-title":"Whole body cholesterol metabolism is impaired in Huntington's disease","volume":"494","author":"Leoni","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.celrep.2022.111953_bib51","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/brain\/awn212","article-title":"Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease","volume":"131","author":"Leoni","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2022.111953_bib52","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/cdd.2014.162","article-title":"Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease","volume":"22","author":"Valenza","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2022.111953_bib53","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2022.111953_bib54","doi-asserted-by":"crossref","first-page":"eabb8920","DOI":"10.1126\/scitranslmed.abb8920","article-title":"Widespread and sustained target engagement in Huntington's disease minipigs upon intrastriatal microRNA-based gene therapy","volume":"13","author":"Vall\u00e8s","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2022.111953_bib55","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.ymthe.2018.06.021","article-title":"AAV5-miHTT gene therapy demonstrates broad distribution and strong human mutant huntingtin lowering in a huntington's disease minipig model","volume":"26","author":"Evers","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2022.111953_bib56","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41467-022-28653-6","article-title":"An orally available, brain penetrant, small molecule lowers huntingtin levels by enhancing pseudoexon inclusion","volume":"13","author":"Keller","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111953_bib57","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1038\/s41467-021-27157-z","article-title":"Small molecule splicing modifiers with systemic HTT-lowering activity","volume":"12","author":"Bhattacharyya","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111953_bib58","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of phenotype in Huntington Disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2022.111953_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2012.01.015","article-title":"An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease","volume":"229","author":"Zarringhalam","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.celrep.2022.111953_bib60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.celrep.2022.111953_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","article-title":"Single-pot, solid-phase-enhanced sample preparation for proteomics experiments","volume":"14","author":"Hughes","year":"2019","journal-title":"Nat. Protoc."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472201854X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472201854X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:56:43Z","timestamp":1761911803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472201854X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S221112472201854X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111953","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal and astrocytic contributions to Huntington\u2019s disease dissected with zinc finger protein transcriptional repressors","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.111953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"111953"}}